Two-year follow-up study of membranous nephropathy treated with tacrolimus and corticosteroids versus cyclical corticosteroids and cyclophosphamide
<h4>Introduction</h4> <p>Both cCTX/GCs and CNIs are recommended as first-line agents in the management of PMN. The present study is an extended report of patients randomized to receive TAC/GCs or cCTX/GCs at 2 years post randomization.</p> <h4>Methods</h4> <p&...
Main Authors: | Ramachandran, R, Yadav, A, Kumar, V, Siva Tez Pinnamaneni, V, Nada, R, Ghosh, R, Rathi, M, Kohli, H, Gupta, K, Sakhuja, V, Jha, V |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2017
|
Similar Items
-
Non-imaging assisted insertion of un-cuffed, non-tunneled internal jugular venous catheters for hemodialysis: Safety and utility in modern day world
by: Manish Rathi, et al.
Published: (2016-08-01) -
Treatment of corticosteroid-refractory alopecia totalis with oral tacrolimus
by: E. Verga, et al.
Published: (2017-08-01) -
COPD: an inhaled corticosteroid-resistant, oral corticosteroid-responsive condition.
by: Saha, S, et al.
Published: (2006) -
Temporal association between PLA2R antibodies and clinical outcomes in primary membranous nephropathy
by: Ramachandran, R, et al.
Published: (2017) -
Comparative analysis between the safety and efficacy of oral corticosteroids versus corticosteroids pulse therapies in IgA nephropathy
by: Yu Wang, et al.
Published: (2023-12-01)